AMRN – Amarin Corp ADR
AMRN — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.16
Margin Of Safety %
-24
Put/Call OI Ratio
0.23
EPS Next Q Diff
0.16
EPS Last/This Y
2.58
EPS This/Next Y
0.39
Price
14.58
Target Price
12
Analyst Recom
4
Performance Q
8.81
Upside
-547.9%
Beta
0.9
Ticker: AMRN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | AMRN | 14.65 | 0.23 | 0.00 | 3869 |
| 2026-03-10 | AMRN | 15.99 | 0.23 | 0.06 | 3830 |
| 2026-03-11 | AMRN | 16.34 | 0.22 | 0.00 | 4049 |
| 2026-03-12 | AMRN | 16.28 | 0.21 | 0.05 | 4164 |
| 2026-03-13 | AMRN | 16.37 | 0.21 | 0.05 | 4164 |
| 2026-03-17 | AMRN | 15.52 | 0.21 | 0.00 | 4193 |
| 2026-03-18 | AMRN | 14.95 | 0.21 | 0.00 | 4190 |
| 2026-03-20 | AMRN | 14.49 | 0.20 | 0.28 | 4419 |
| 2026-03-25 | AMRN | 14.72 | 0.31 | 0.13 | 2166 |
| 2026-03-26 | AMRN | 14.65 | 0.29 | 0.23 | 2382 |
| 2026-03-27 | AMRN | 14.44 | 0.28 | 0.63 | 2540 |
| 2026-03-30 | AMRN | 13.88 | 0.29 | 0.11 | 2555 |
| 2026-03-31 | AMRN | 14.44 | 0.27 | 0.07 | 2620 |
| 2026-04-01 | AMRN | 14.64 | 0.25 | 0.03 | 2912 |
| 2026-04-06 | AMRN | 14.59 | 0.24 | 0.00 | 3074 |
| 2026-04-07 | AMRN | 14.58 | 0.23 | 0.09 | 3100 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | AMRN | 14.62 | 142.5 | - | 0.78 |
| 2026-03-10 | AMRN | 15.92 | 142.5 | - | 0.78 |
| 2026-03-11 | AMRN | 16.29 | 142.5 | - | 0.78 |
| 2026-03-12 | AMRN | 16.28 | 142.5 | - | 0.78 |
| 2026-03-13 | AMRN | 15.33 | 142.5 | - | 0.78 |
| 2026-03-17 | AMRN | 15.46 | 142.5 | - | 0.78 |
| 2026-03-18 | AMRN | 14.94 | 142.5 | - | 0.78 |
| 2026-03-19 | AMRN | 14.95 | 142.5 | - | 0.78 |
| 2026-03-20 | AMRN | 14.48 | 142.5 | - | 0.78 |
| 2026-03-23 | AMRN | 14.78 | 142.5 | - | 0.78 |
| 2026-03-24 | AMRN | 14.47 | 142.5 | - | 0.78 |
| 2026-03-25 | AMRN | 14.62 | 142.5 | - | 0.78 |
| 2026-03-26 | AMRN | 14.60 | 142.5 | - | 0.78 |
| 2026-03-27 | AMRN | 14.32 | 142.5 | - | 0.78 |
| 2026-03-30 | AMRN | 13.94 | 142.5 | - | 0.78 |
| 2026-03-31 | AMRN | 14.32 | 142.5 | - | 0.78 |
| 2026-04-01 | AMRN | 14.64 | 142.5 | - | 0.78 |
| 2026-04-02 | AMRN | 14.71 | 142.5 | - | 0.78 |
| 2026-04-06 | AMRN | 14.59 | 142.5 | - | 0.78 |
| 2026-04-07 | AMRN | 14.58 | 142.5 | - | 0.78 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | AMRN | 0.00 | -0.01 | 1.98 |
| 2026-03-10 | AMRN | 0.00 | -0.01 | 1.98 |
| 2026-03-11 | AMRN | 0.00 | -0.01 | 2.11 |
| 2026-03-12 | AMRN | 0.00 | -0.01 | 2.11 |
| 2026-03-13 | AMRN | 0.00 | -0.01 | 2.11 |
| 2026-03-18 | AMRN | 0.00 | 0.02 | 2.11 |
| 2026-03-19 | AMRN | 0.00 | 0.02 | 2.11 |
| 2026-03-20 | AMRN | 0.00 | 0.02 | 2.11 |
| 2026-03-23 | AMRN | 0.00 | 0.02 | 2.11 |
| 2026-03-24 | AMRN | 0.00 | 0.02 | 2.11 |
| 2026-03-25 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-03-26 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-03-27 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-03-30 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-03-31 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-04-01 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-04-02 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-04-06 | AMRN | 0.00 | 0.02 | 2.16 |
| 2026-04-07 | AMRN | 0.00 | 0.02 | 2.16 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.01
Avg. EPS Est. Current Quarter
0.17
Avg. EPS Est. Next Quarter
0.17
Insider Transactions
Institutional Transactions
0.02
Beta
0.9
Average Sales Estimate Current Quarter
43
Average Sales Estimate Next Quarter
43
Fair Value
11.03
Quality Score
49
Growth Score
33
Sentiment Score
66
Actual DrawDown %
88.8
Max Drawdown 5-Year %
-93.8
Target Price
12
P/E
Forward P/E
267.09
PEG
P/S
1.43
P/B
0.67
P/Free Cash Flow
EPS
-1.88
Average EPS Est. Cur. Y
0.78
EPS Next Y. (Est.)
1.17
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-18.19
Relative Volume
0.42
Return on Equity vs Sector %
-35.9
Return on Equity vs Industry %
-45.2
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.19
EBIT Estimation
◆
AMRN
Healthcare
$14.69
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
48.9
Range 1M
29.9%
Sup Dist
1.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
133.3%
EPS NY
83.3%
52W%
52.6%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+78.3% upside
Upside
+78.3%
Quality
49
MoS
-24%
Amarin Corporation plcSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 80
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
AMRN
Latest News
—
Caricamento notizie per AMRN…
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading